Biodesix (BDSX) Income from Continuing Operations (2019 - 2026)
Biodesix's (BDSX) quarterly Income from Continuing Operations came in at 8499000.0 in Q1 2026, up 21.46% YoY from 6997464.73 in Q1 2025, and down 111.1% on a QoQ basis from 4026000.0 in Q4 2025.
Biodesix (BDSX) Income from Continuing Operations (2019 - 2026) Analysis & Trends
Biodesix (BDSX) has 8 years of Income from Continuing Operations data on file, last reported at 8499000.0 in Q1 2026.
- Quarterly Income from Continuing Operations rose 21.46% year-over-year to 8499000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 88388000.0 (down 120.83% YoY) and the FY2025 annual result came in at 134398000.0, down 0.68% from the prior year.
- Income from Continuing Operations retreated to 8499000.0 in Q1 2026, from 4026000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 4026000.0 in Q4 2025 to a low of 64637000.0 in Q1 2023.
- A 5-year average of 21615058.82 and a median of 13165000.0 in 2023 frame the typical range for Income from Continuing Operations.
- Annual changes were most pronounced in 2024 — Income from Continuing Operations soared 79.04% — and 2025, when it sank 412.78%.
- Tracing BDSX's Income from Continuing Operations over 5 years: stood at 9377000.0 in 2022, then tumbled by 40.4% to 13165000.0 in 2023, then surged by 36.19% to 8401000.0 in 2024, then surged by 52.08% to 4026000.0 in 2025, then plunged by 111.1% to 8499000.0 in 2026.
- The last three Income from Continuing Operations figures came in at 8499000.0 (Q1 2026), 4026000.0 (Q4 2025), and 23703000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 338.41 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | -85.11 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 324.00 Mn |
| 10 | Biodesix | 220.74 Mn | 195.16 Mn | 21.35 Mn | -8.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.50 Mn |
| Dec 31, 2025 | -4.03 Mn |
| Sep 30, 2025 | -23.70 Mn |
| Jun 30, 2025 | -52.16 Mn |
| Mar 31, 2025 | -10.82 Mn |
| Dec 31, 2024 | -8.40 Mn |
| Sep 30, 2024 | -10.63 Mn |
| Jun 30, 2024 | -10.17 Mn |
| Mar 31, 2024 | -13.55 Mn |
| Dec 31, 2023 | -13.17 Mn |
| Sep 30, 2023 | -12.26 Mn |
| Jun 30, 2023 | -33.87 Mn |
| Mar 31, 2023 | -64.64 Mn |
| Dec 31, 2022 | -9.38 Mn |
| Sep 30, 2022 | -34.77 Mn |
| Jun 30, 2022 | -40.41 Mn |
| Mar 31, 2022 | -17.01 Mn |
| Dec 31, 2021 | -10.34 Mn |
| Sep 30, 2021 | -24.40 Mn |
| Jun 30, 2021 | -31.39 Mn |